Consistently with previous studies, our results indicate that SALL4 in concert with other stemness markers like OCT4, NANOG, and SOX2 can drive reprogramming of cancer cells toward a CSC-like phenotype mediated by the TWIST1 expression. This evidence concerns the gene TWIST1 and cancer.